New bioanalytical assays were developed, validated, and applied in a clinical study for quantitative measurement of acetaminophen concentrations in blood and plasma samples. Furthermore, after validation, the bioanalytical assays were used for determination of pharmacokinetics within a group of six healthy male human volunteers after admission of a single oral dose of 500 mg of acetaminophen. Quantitative analyses were done by means of liquid chromatography‐high resolution mass spectrometry and blood samples were collected at various sampling time points using different peripheral blood microsampling techniques. Post‐dose peripheral collected blood samples were applied for the preparation of dry blood spots, dried matrix on paper discs, and peripheral plasma. Pharmacokinetic parameters determined were clearance (Cl), area under the curve (AUC), volume of distribution (V d ), peak concentration (C max ), time of occurrence of peak concentration (T max ) and half‐life time (T ½ ). Observed pharmacokinetic values were not statistically (ANOVA) different compared to in literature reported values based on venous blood collection. The present pilot study demonstrated the feasibility of peripheral blood microsampling techniques in combination with quantitative liquid chromatography‐high resolution mass spectrometry analysis for the determination of pharmacokinetics in clinical studies. Copyright © 2013 John Wiley & Sons, Ltd.